Senior Director, State Government Affairs at Eli Lilly and Company

Austin, Texas, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Bachelor’s degree in political science or related fields
10+ years of experience in government affairs or related lobbying experience
Qualified applicants must be authorized to work in the United States on a full-time basis
Specialized knowledge of the legislative and regulatory process in multiple geographies (preferred)
Excellent communication and interpersonal skills (preferred)
Business acumen (preferred)
Ability to work across boundaries and networks (preferred)
Ability to lead in a complex environment and to solve complex problems with broad impact on legislation and Lilly’s business (preferred)
Ability to lead through controversial issues impacting the business (preferred)

Responsibilities

Develop and implement Lilly’s government affairs strategy with tight alignment with Lilly’s Business Units – Cardiometabolic Health, Immunology, Neuroscience, and Oncology
Make technical (business and legislative) decisions within Lilly and with external entities
Lead large-scale projects or campaigns with awareness of legislative and business risks
Manage Lilly’s relationship with key customers and function as a principal government affairs representative with civic and community organizations, disease state organizations, governors, their cabinet and executive staff, state legislatures, state regulatory agencies, and local elected officials
Develop and manage relationships with key advocacy and business organizations that align with Lilly’s business and legislative objectives
Support Lilly’s state government affairs team by leveraging relationships with prominent governors, their executive staff, and state legislators
Engage with civic and community organizations within the region
Secure and strengthen alliances with state-based disease state patient organizations to support Lilly’s business and legislative objectives
Support Lilly’s Federal office (in Washington, D.C.) by leveraging relationships with prominent members of the congressional delegation from priority states
Influence decisions within the government affairs team and external partners on legislative issues that align with Lilly’s business objectives
Analyze and anticipate changes to public and private business environment in areas of direct responsibility; identify trends and stay abreast of the external environment for issues and actions that could affect present and future business opportunities
Manage a budget and the activities of consultants

Skills

Government Affairs

Legislative Strategy

Stakeholder Management

Relationship Building

Advocacy

Public Policy

Cross-Functional Leadership

Project Management

Risk Assessment

Alliance Building

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free